Results 151 to 160 of about 160,198 (339)

Angiotensin II receptor blockade in diabetic nephropathy [PDF]

, 2002
Michael Ruddy
openalex   +1 more source

IRBIT a Master Regulator of Cell Physiology [PDF]

, 2017
(excerpt) Hormones and neurotransmitters regulate cell functions by binding to their receptors, which activate intracellular signaling and produce the physiological response [1].
Bouyer, Patrice G, Cook, Kelli, Petreska, Natasa   +2 more
core   +1 more source

Possible therapeutic repositioning of valproic acid: From epileptic seizures to acute kidney injury

British Journal of Clinical Pharmacology, EarlyView.
Valproic acid, an anticonvulsant, may be repositioned to prevent acute kidney injury due to ischemia followed by reperfusion. It preserves renal functions, electrolyte homeostasis and active sodium transport in kidney tubules, and blocks the onset of hypertension.
Danilo Alves‐Bezerra, Luiza B. Negreiros, Amaury Pereira‐Acácio, Isadora G. Almeida, João P. M. Veloso‐Santos, Jarlene A. Lopes, Glória Costa‐Sarmento, Humberto Muzi‐Filho, Adalberto Vieyra   +8 more
wiley   +1 more source

The nonselective cation channel TRPV4 inhibits angiotensin II receptors. [PDF]

J Biol Chem, 2020
Zaccor NW, Sumner CJ, Snyder SH.
europepmc   +1 more source

Effect of angiotensin II type 1 receptor blockade on kidney ischemia/reperfusion; a gender-related difference [PDF]

, 2016
Fatemeh Moslemi, Pegah Taheri, Mahdis Azimipoor, Sina Ramtin, Mostafa Hashemianfar, Ali Momeni- Ashjerdi, Fatemeh Eshraghi-Jazi, Ardeshir Talebi, Hamid Nasri, Mehdi Nematbakhsh   +9 more
openalex   +1 more source

The Prevalence and Implications of Polypharmacy in Individuals With Type 1 Diabetes

Clinical Pharmacology &Therapeutics, EarlyView.
Polypharmacy is increasingly recognized as a relevant issue in diabetes care, but its prevalence and clinical relevance in individuals with type 1 diabetes remain underexplored. This study aimed to determine the prevalence of polypharmacy and to identify associated clinical and psychological factors. Participants were recruited from a tertiary diabetes
Namam Ali, Stephan van Erp, Cornelis Kramers, Cornelis J. Tack, Bastiaan E. de Galan   +4 more
wiley   +1 more source

Transactivation of the Insulin-Like Growth Factor-I Receptor by Angiotensin II Mediates Downstream Signaling from the Angiotensin II Type 1 Receptor to Phosphatidylinositol 3-Kinase [PDF]

, 2004
Peter Zahradka, Brenda Litchie, Ben Storie, Gail Helwer   +3 more
openalex   +1 more source

Angiotensin II Type 2 Receptor Agonist Reduces the Inflammation and Pain Hypersensitivity in Mice with Joint Inflammatory Pain

, 2022
Wei Gao, Liang Shen, Dan-dan Long, Tingting Pan, Di Wang, Xiaoqing Chai, Shanshan Hu   +6 more
openalex   +1 more source

Characterizing Alzheimer’s Disease and Related Dementia in a Hypertension Population Within the State of Florida Using Electronic Health Record–Based Data

Clinical Pharmacology &Therapeutics, EarlyView.
Hypertension is a known modifiable risk factor for Alzheimer’s disease and related dementia (ADRD). However, it is unknown how variance in hypertension control, antihypertensive medications, and social determinants of health, such as social deprivation index (SDI), influence the risk of developing ADRD.
Eissa A. Jafari, Mona Alshahawey, Muhammad A. Zaman, Steven M. Smith, Yan Gong, Glenn E. Smith, Caitrin W. McDonough   +6 more
wiley   +1 more source

Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment.

JAMA Netw Open, 2022
Marcum ZA, Cohen JB, Zhang C, Derington CG, Greene TH, Ghazi L, Herrick JS, King JB, Cheung AK, Bryan N, Supiano MA, Sonnen JA, Weintraub WS, Williamson J, Pajewski NM, Bress AP, Systolic Blood Pressure Intervention Trial (SPRINT) Research Group.   +16 more
europepmc   +1 more source